Sign in

CIK 0002036042 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Sionna Therapeutics, Inc.

Sign in to watch
Ticker
SION
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-819-2020
Business address
21 HICKORY DRIVE, SUITE 500, WALTHAM, MA, 02451
  1. 4 Planned sale Director sold 101 shares at $44.49 ($4,493)
  2. 4 Planned sale Director sold 292,952 shares at an average $45.62 ($13,364,065)
  3. 4 Planned sale Director sold 292,952 shares at an average $45.62 ($13,364,065)
  4. 4 Planned sale Director sold 55,345 shares at an average $44.67 ($2,472,343)
  5. 4 Planned sale Director sold 55,345 shares at an average $44.67 ($2,472,343)
  6. 4 Planned sale Director sold 510,583 shares at an average $44.94 ($22,945,044)
  7. 4 Planned sale Director sold 510,583 shares at an average $44.94 ($22,945,044)
  8. 4 Planned sale Chief Legal Officer sold 10,250 shares at $33.86 ($347,019)
  9. 4 Planned sale Director sold 30,953 shares at an average $44.58 ($1,379,866)
  10. 4 Planned sale Director sold 30,953 shares at an average $44.58 ($1,379,866)
  11. 4 Open-market sale 10% owner sold 250,000 shares at $40.00 ($10,000,000)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Planned sale Director sold 33,356 shares at $44.55 ($1,486,010)
  18. 4 Planned sale Director sold 33,356 shares at $44.55 ($1,486,010)
  19. 4 Planned sale Director sold 1,875 shares at an average $44.49 ($83,428)
  20. 4 Planned sale Director sold 1,875 shares at an average $44.49 ($83,428)

Page 2 of 5 · 100 filings